Results 81 to 90 of about 6,146 (129)

[Advances in targeted therapies for chronic spontaneous urticaria]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Zhou L, Hu C, Wang S, Zhang R.
europepmc   +1 more source

[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Translational Medicine Branch, China Association of Gerontology and Geriatrics, Society of Hepatology, Beijing Medical Association, Expert Committee on Liver Cancer, Chinese Society of Clinical Oncology.   +5 more
europepmc   +1 more source

[Guideline for the diagnosis and treatment of chronic myeloid leukemia in China (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Chinese Society of Hematology, Chinese Medical Association.   +1 more
europepmc   +1 more source

[Antitumor component-Ι in <i>Agkistrodon halys</i> venom inhibits proliferation and migration of cisplatin-resistant gastric cancer cells by downregulating RAI14]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li Y, Li CDC, Guo R, Han H, Lu L, Zhou F, Zhi H, 支 慧.   +7 more
europepmc   +1 more source

[Identification of SORD as A Key Gene Mediating Osimertinib Primary Resistance 
in EGFR-Mutant Lung Adenocarcinoma via Machine Learning and Methylomics]. [PDF]

Zhongguo Fei Ai Za Zhi
Liang G, Wu H, Jia C, Gao P, Zhang Z, Chen C, Li Y, Liu H, Chen J.   +8 more
europepmc   +1 more source

氩激光小梁成形术治疗开角型青光眼——4年随访报告

Zhongshan Daxue xuebao. Yixue kexue ban, 1990
用氩激光小梁成形术(ALT)治疗79例105眼开角型青光眼的4年疗效。总有效率78％,平均眼压下降1.34kPa(10.04mmHg),4年内疗效稳定。全部病例均为最大耐受量药物治疗无效拟作滤过性手术者,ALT术后83％病例在4年内可避免作滤过性手术。失败的23眼中有21眼在ALT后半年内眼压回升,另2眼在第3年回升,18眼(17％)须作滤过性手术。ALT术后42.9％的病例其用药种数减少。年岁较大(>60岁 ...
doaj  

[Progress in clinical research related to viral hepatitis in 2025]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ding Y, Li Y, Dou XG.
europepmc   +1 more source

[Research progress on toxic shock syndrome due to group A <i>Streptococcus</i> infection in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wang HY, Zhou W, Huang LS.
europepmc   +1 more source

[Efficacy and Safety of High-dose Furmonertinib plus Intrathecal Pemetrexed 
for EGFR-mutant Non-small Cell Lung Cancer with Leptomeningeal Metastasis]. [PDF]

Zhongguo Fei Ai Za Zhi
Chen X, He M, Chen C, Jiang C, Li H, Lin Y, Yu T, Xie Y, Guo A, Huang M, Yin Z, Zhang T.   +11 more
europepmc   +1 more source

[Clinical research advances for small-molecule nucleic acid drugs in the treatment of chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang WX, Guo YM, Fei ZX, Zhu SS, Wang FS.   +4 more
europepmc   +1 more source